Medical Xpress
Global hypertension study finds fight against high blood pressure falling short
Despite hypertension being one of the most detectable and treatable conditions in medicine, a sweeping new global study reveals that efforts to bring high blood pressure under control are failing on a massive scale. The findings expose a critical gap between what is medically possible and what is actually being delivered to patients worldwide. With hypertension a leading driver of heart disease and stroke, the shortfall carries serious consequences for public health systems already under strain.
Read article →Medical Xpress
Popular weight loss and anti-inflammatory drugs may help prevent common heart rhythm disorder
Two widely used drugs — semaglutide, the active ingredient in popular weight loss medications, and colchicine, a longstanding anti-inflammatory — may offer a new line of defense against atrial fibrillation, one of the world's most common heart rhythm disorders. Researchers at Ben-Gurion University mapped the biological mechanisms by which both drugs protect cardiac structure and electrical signaling, laying groundwork for preventive treatment strategies. The findings, published in *Europace*, could shift clinical thinking toward intervening before AF develops rather than managing it after the fact.
Read article →Medical Xpress
Personalized mRNA vaccine targets osteosarcoma relapse in first human use
Doctors at Houston Methodist have administered the first personalized mRNA cancer vaccine targeting osteosarcoma, a rare and aggressive bone cancer with high recurrence rates. The vaccine, cleared by the FDA under compassionate use, is custom-designed to prime a patient's immune system against their specific tumor profile. The milestone marks a significant advance in personalized oncology and could lay the groundwork for mRNA-based approaches across other hard-to-treat cancers.
Read article →Guardian Health
Rise in sickle cell disease prompts NHS call for more Black blood donors
Demand for blood used to treat sickle cell disease has surged 132% over the past decade, with the NHS now requiring more than 191,000 units of HbS-negative blood annually compared to 82,000 in 2015. The NHS is urgently calling for more Black donors, as HbS-negative blood is far more prevalent among Black populations and closely matched donor blood reduces the risk of complications for patients. The shortfall underscores a growing public health challenge as sickle cell disease — primarily affecting people of African and Caribbean heritage — becomes one of the UK's most common genetic disorders.
Read article →
Stat News
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
Regenxbio has announced positive clinical trial results for its Duchenne muscular dystrophy gene therapy, clearing the path for an FDA filing. The milestone marks a significant step forward in addressing one of the most severe and currently incurable genetic diseases. A regulatory submission would put the treatment on track for potential approval and commercial availability.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →